União Química has Innovation as a major pillar of strategic development, with an annual investment of 7% of revenue in Research and Development. One of the highlights was the creation of an internal Development Center aimed at expanding the portfolio, to support the strategy of launching medicines in the areas of Medical Prescription, OTC, Food and Cosmetics in Human Health and Animal Health.

Highly attractive with strong growth paths.
Favorable prospects for the Brazilian pharmaceutical market
One of the largest companies in the national pharmaceutical industry
State-of-the-art infrastructure with state-of-the-art R&D facilities
Strong financial results with highly diversified revenue stream
Average net revenue growth of 27% in the last 5 years.

Thinking about the future of people, health and business, in addition to actions in our water reuse and effluent treatment plants, among others, in the year that União Química completed 85 years, we launched the Raízes da União Program, which has the objective of planting 1 million native trees.